Emergent Biosolutions EBS Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's pre-tax income?
- Emergent Biosolutions (EBS) reported pre-tax income of $13.4M in Q1 2026.
- How has Emergent Biosolutions's pre-tax income changed year-over-year?
- Emergent Biosolutions's pre-tax income decreased by 85.5% year-over-year, from $92.7M to $13.4M.
- What is the long-term trend for Emergent Biosolutions's pre-tax income?
- Over 3 years (2021 to 2024), Emergent Biosolutions's pre-tax income has grown at a -22.2% compound annual growth rate (CAGR), from $303.2M to -$142.9M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.